Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
MICHAEL S BLAISS
Listed Specialty: Allergy & Immunology
7205 WOLF RIVER BLVD, SUITE 200, GERMANTOWN, TN, 38138-1746
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
MICHAEL BLAISS,
Yearly Payment Breakdown:
2018 Payments At a Glance
59
payments
$57,699
payment total
9
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
6 | $31,920 |
Promotional Speaking/Other |
5 | $16,476 |
Travel and Lodging |
25 | $7,515 |
Food and Beverage |
23 | $1,788 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
DUPIXENT |
drug |
$21,125 |
NO PRODUCT DISCUSSED |
drug |
$14,741 |
ODACTRA |
drug |
$13,209 |
GENERAL BRONCHIAL THERMOPLASTY |
device |
$6,673 |
Payments with no listed product |
N/A |
$1,209 |
THERAPIES |
device |
$534 |
FASENRA |
drug |
$110 |
ORALAIR |
drug |
$49 |
GENERAL PULMONARY |
device |
$49 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| May 22, 2018 | $6,540 | NO PRODUCT DISCUSSED | Consulting | GENZYME CORPORATION | |
| May 31, 2018 | $6,460 | DUPIXENT | Consulting | REGENERON HEALTHCARE SOLUTIONS, INC. | |
| May 9, 2018 | $6,460 | DUPIXENT | Consulting | REGENERON PHARMACEUTICALS, INC. | |
| May 9, 2018 | $6,400 | GENERAL BRONCHIAL THERMOPLASTY | Promotional Speaking/Other | BOSTON SCIENTIFIC CORPORATION | |
| Jan 30, 2018 | $6,000 | NO PRODUCT DISCUSSED | Consulting | SANOFI-AVENTIS U.S. LLC | |
| Oct 24, 2018 | $5,000 | ODACTRA | Promotional Speaking/Other | ALK-ABELLO, INC | |
| Aug 19, 2018 | $3,420 | DUPIXENT | Consulting | REGENERON HEALTHCARE SOLUTIONS, INC. | |
| May 9, 2018 | $3,040 | DUPIXENT | Consulting | REGENERON PHARMACEUTICALS, INC. | |
| Apr 24, 2018 | $2,500 | ODACTRA | Promotional Speaking/Other | ALK-ABELLO, INC | |
| Apr 25, 2018 | $2,500 | ODACTRA | Promotional Speaking/Other | ALK-ABELLO, INC | |
| May 14, 2018 | $722 | No Listed Product | Travel and Lodging | ASTRAZENECA PHARMACEUTICALS LP | |
| Oct 24, 2018 | $674 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| May 22, 2018 | $605 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
| Jan 30, 2018 | $595 | NO PRODUCT DISCUSSED | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Mar 15, 2018 | $592 | DUPIXENT | Travel and Lodging | REGENERON PHARMACEUTICALS, INC. | |
| Apr 22, 2018 | $534 | THERAPIES | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | |
| Apr 25, 2018 | $463 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Apr 10, 2018 | $415 | DUPIXENT | Travel and Lodging | REGENERON PHARMACEUTICALS, INC. | |
| Apr 25, 2018 | $383 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Apr 24, 2018 | $378 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Jan 30, 2018 | $340 | NO PRODUCT DISCUSSED | Food and Beverage | SANOFI-AVENTIS U.S. LLC | |
| Oct 24, 2018 | $328 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Jan 30, 2018 | $228 | NO PRODUCT DISCUSSED | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Jan 30, 2018 | $210 | NO PRODUCT DISCUSSED | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Apr 24, 2018 | $207 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Nov 13, 2018 | $153 | No Listed Product | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| May 31, 2018 | $144 | DUPIXENT | Travel and Lodging | REGENERON HEALTHCARE SOLUTIONS, INC. | |
| May 9, 2018 | $136 | GENERAL BRONCHIAL THERMOPLASTY | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | |
| Apr 25, 2018 | $135 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| May 22, 2018 | $134 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
| Apr 24, 2018 | $130 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| Nov 13, 2018 | $125 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| May 9, 2018 | $123 | GENERAL BRONCHIAL THERMOPLASTY | Travel and Lodging | BOSTON SCIENTIFIC CORPORATION | |
| Oct 24, 2018 | $119 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| Apr 10, 2018 | $118 | DUPIXENT | Food and Beverage | REGENERON PHARMACEUTICALS, INC. | |
| Mar 29, 2018 | $110 | DUPIXENT | Travel and Lodging | REGENERON PHARMACEUTICALS, INC. | |
| Feb 21, 2018 | $110 | FASENRA | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
| Apr 10, 2018 | $108 | DUPIXENT | Food and Beverage | REGENERON PHARMACEUTICALS, INC. | |
| Jan 30, 2018 | $89 | NO PRODUCT DISCUSSED | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Apr 24, 2018 | $89 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| May 9, 2018 | $84 | DUPIXENT | Travel and Lodging | REGENERON PHARMACEUTICALS, INC. | |
| May 27, 2018 | $80 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| Oct 24, 2018 | $79 | ODACTRA | Travel and Lodging | ALK-ABELLO, INC | |
| Oct 24, 2018 | $76 | ODACTRA | Promotional Speaking/Other | ALK-ABELLO, INC | |
| Aug 3, 2018 | $74 | No Listed Product | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
| Apr 10, 2018 | $74 | DUPIXENT | Food and Beverage | REGENERON PHARMACEUTICALS, INC. | |
| Apr 10, 2018 | $58 | DUPIXENT | Food and Beverage | REGENERON PHARMACEUTICALS, INC. | |
| Nov 14, 2018 | $50 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Apr 23, 2018 | $49 | GENERAL PULMONARY | Food and Beverage | BOSTON SCIENTIFIC CORPORATION | |
| Oct 25, 2018 | $48 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| Mar 15, 2018 | $40 | DUPIXENT | Travel and Lodging | REGENERON PHARMACEUTICALS, INC. | |
| Nov 14, 2018 | $35 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Nov 14, 2018 | $25 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Nov 14, 2018 | $25 | No Listed Product | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| May 26, 2018 | $22 | ODACTRA | Food and Beverage | ALK-ABELLO, INC | |
| Oct 19, 2018 | $22 | ORALAIR | Food and Beverage | GREER LABORATORIES, INC. | |
| May 9, 2018 | $14 | GENERAL BRONCHIAL THERMOPLASTY | Food and Beverage | BOSTON SCIENTIFIC CORPORATION | |
| Feb 1, 2018 | $14 | ORALAIR | Food and Beverage | GREER LABORATORIES, INC. | |
| Jul 14, 2018 | $13 | ORALAIR | Food and Beverage | GREER LABORATORIES, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.